☆ 4.3 Editorial Material

Orphan drug designation for pracinostat, volasertib and alvocidib in AML

LEUKEMIA RESEARCH (2014)

Get Full Text
Add to Collection

Journal

LEUKEMIA RESEARCH
Volume 38, Issue 8, Pages 862-865

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.leukres.2014.06.007

Keywords

AML; Pracinostat; Alvocidib; Flavopiridol; Volasertib; Rational combinations

Categories

Oncology Hematology

Funding

  1. NCI NIH HHS [R01 CA167708-01A1, R01 CA100866-09, P30 CA016672] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.